Use of Activated Recombinant Human Factor VII in Cardiac Surgery

NCT00154427 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

172

Enrollment

INDUSTRY

Sponsor class

Stopped Trial terminated after recruiting 172 patients but without proceeding to the highest dosing cohort as this no longer reflects common clinical practice

Conditions

Acquired Bleeding Disorder
Cardiac Surgery Requiring Cardiopulmonary Bypass

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S